<?xml version="1.0" encoding="UTF-8"?>
<p>According to WHO, based on evidence from laboratory, animal, and clinical studies, the drugs which are advised for treatment of COVID-19 are Remdesivir, Lopinavir/Ritonavir, Lopinavir/Ritonavir with interferon beta-1a, chloroquine, and hydroxychloroquine. Remdesivir has been previously tested for Ebola treatment (
 <xref rid="ref15" ref-type="bibr">15</xref>). According to a recent study, an inflammatory drug, baricitinib, when used in combination with anti-viral drugs like Remidesivir, increases the potential of the drug to reduce viral infection (
 <xref rid="ref16" ref-type="bibr">16</xref>). The Lopinavir/Ritonavir drug is currently provided to treat HIV infection; from the laboratory experiments, it is evident that these combinational drugs could be used to treat the COVID-19 infections. According to the (
 <xref rid="ref15" ref-type="bibr">15</xref>), the interferon beta-1a, which is used to treat multiple sclerosis, can also be used as a remedial approach for COVID-19 disease. Ongoing clinical trials used to treat COVID-19 (
 <xref rid="T2" ref-type="table">Table 2</xref>) and drugs in use have been updated (
 <xref rid="T3" ref-type="table">Table 3</xref>).
</p>
